| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 278.71B | 268.23B | 231.95B | 188.32B | 153.35B |
| Gross Profit | 210.62B | 172.91B | 147.40B | 115.24B | 93.55B |
| EBITDA | 52.29B | 49.58B | 43.29B | 32.48B | 28.30B |
| Net Income | 2.31B | 1.87B | 5.46B | 3.83B | 8.98B |
Balance Sheet | |||||
| Total Assets | 309.07B | 323.20B | 321.44B | 266.24B | 240.84B |
| Cash, Cash Equivalents and Short-Term Investments | 69.89B | 82.27B | 70.63B | 67.46B | 53.46B |
| Total Debt | 187.64B | 200.88B | 194.80B | 167.43B | 154.68B |
| Total Liabilities | 230.57B | 240.52B | 242.15B | 198.93B | 181.71B |
| Stockholders Equity | 78.56B | 73.39B | 69.75B | 58.72B | 51.18B |
Cash Flow | |||||
| Free Cash Flow | 35.44B | 23.84B | 33.70B | 21.18B | 28.22B |
| Operating Cash Flow | 49.24B | 37.67B | 42.79B | 32.59B | 35.12B |
| Investing Cash Flow | -15.66B | -12.79B | -26.75B | -11.42B | 9.78B |
| Financing Cash Flow | -48.13B | -13.22B | -16.61B | -9.23B | -18.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.08T | 24.95 | 13.08% | 0.76% | 3.46% | 13.52% | |
63 Neutral | ¥111.77B | 272.82 | ― | 0.70% | 6.85% | 45.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥205.38B | 37.97 | ― | 0.69% | 10.09% | 22.64% | |
58 Neutral | ¥126.46B | 31.47 | ― | 0.63% | 5.09% | 30.45% | |
56 Neutral | ¥1.19T | 31.37 | 15.36% | 0.78% | 11.21% | 9.99% | |
50 Neutral | ¥325.01B | -15.10 | ― | 0.24% | 3.91% | 37.05% |